The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical […]
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to ascertain the balance of benefits and harms of screening asymptomatic adults […]
(HealthDay)—Geographic and temporal differences were identified in racial and ethnic disparities in COVID-19 hospitalization levels during 2020, according to research published in the April 12 early-release […]